Related Experiment Video
Updated: Aug 19, 2026

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children
Rita J Jeremy1, Soyeon Kim, Molly Nozyce
1Pediatric Clinical Research Center, Department of Pediatrics, School of Medicine, University of California-San Francisco, 505 Parnassus Ave, San Francisco, CA 94143-0105, USA. jeremyr@peds.ucsf.edu
Insights
HIV-infected children exhibit poorer neuropsychological functioning, especially with higher viral loads. Antiretroviral therapy improved vocabulary but not overall cognitive function, necessitating revised treatment strategies for HIV disease.
Area of Science:
- Pediatric infectious diseases
- Neuroimmunology
- Clinical pharmacology
Background:
- HIV infection in children can impact neurodevelopment.
- Antiretroviral therapy (ART) is crucial for managing HIV but its effect on neuropsychological functioning requires further investigation.
- Previous treatment regimens may influence outcomes after treatment changes.
Purpose of the Study:
- To investigate neuropsychological functioning in previously treated HIV-infected children.
- To examine the correlation between viral load and neuropsychological performance.
- To evaluate the impact of a new treatment regimen, including protease inhibitors (PIs), on neuropsychological outcomes.
Main Methods:
- 489 HIV-infected children (4 months to 17 years) previously treated with ART were randomized to 7 different treatment combinations (6 with PIs).
- Neuropsychological functioning was assessed using 13 age-appropriate measures of cognitive, neurologic, and behavioral function.
- Children were prospectively evaluated for 48 weeks, monitoring changes in neuropsychological performance and viral load.
Main Results:
- At baseline, HIV-infected children showed poorer neuropsychological functioning compared to age-matched norms.
- Higher viral load at baseline was associated with poorer cognitive, fine-motor, and neurologic function.
- After 48 weeks of PI-containing therapy, only vocabulary scores significantly improved; overall neuropsychological functioning remained below norms even with undetectable viral loads.
Conclusions:
- HIV-infected children present with significant neuropsychological deficits, exacerbated by higher viral loads.
- Current PI-containing combination therapies show limited efficacy in restoring neuropsychological functioning.
- Treatment strategies for pediatric HIV disease should be reevaluated to prioritize neuropsychological recovery alongside viral load suppression.
Objective:
Neuropsychological functioning and its correlation with viral load were investigated for previously treated HIV-infected children who underwent a change in treatment regimen.
Methods:
Thirteen age-appropriate measures of cognitive, neurologic, and behavioral functioning were administered to 489 HIV-infected children who were aged 4 months to 17 years and had been treated previously for at least 16 weeks with antiretroviral therapy. These clinically and immunologically stable children were randomized onto 1 of 7 drug treatment combinations, 6 of which included a protease inhibitor (PI), and evaluated prospectively for 48 weeks with respect to changes in neuropsychological performance and viral load.
Results:
Neuropsychological functioning was significantly poorer at baseline for the HIV-infected children as compared with established norms for their age. Children with higher viral load had poorer cognitive, both-hands fine-motor, and neurologic signs at baseline, but single-hand fine-motor and behavioral functioning were not correlated with viral load. After 48 weeks of treatment with PI-containing combination therapy, there was significant improvement in only the vocabulary score. Neuropsychological changes did not differ among the 6 PI-containing combination regimens. At week 48, even children with a viral load response below the level of detection (RNA < or =400 copies/mL) still showed poorer neuropsychological functioning compared with established norms.
Conclusion:
Poor neuropsychological functioning was seen for HIV-infected children and was worse for children with higher viral loads. Only 1 measure of neuropsychological functioning showed improvement after treatment with PI-containing combination therapy, and the extent of that improvement was relatively minor. Treatment strategies for children with HIV disease need to be reevaluated so that they consider restoration of neuropsychological functioning in addition to lowering the viral load.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Inhibitors of Virion Maturation and Assembly
Cytomegalovirus Disease
